Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41K Sell
1,719
-14
-0.8% -$366 0.01% 270
2026
Q1
$48K Buy
1,733
+184
+12% +$4.9K 0.01% 212
2025
Q4
$38K Sell
1,549
-130
-8% -$3.28K 0.01% 243
2025
Q3
$42K Buy
1,679
+53
+3% +$1.31K 0.01% 235
2025
Q2
$39K Sell
1,626
-151
-8% -$3.52K 0.01% 227
2025
Q1
$47K Hold
1,777
0.01% 195
2024
Q4
$47K Sell
1,777
-81
-4% -$2.2K 0.01% 195
2024
Q3
$53K Sell
1,858
-339
-15% -$9.89K 0.01% 166
2024
Q2
$61K Buy
2,197
+1,223
+126% +$33.7K 0.02% 148
2024
Q1
$28K Sell
974
-798
-45% -$22.1K 0.01% 198
2023
Q4
$51K Sell
1,772
-221
-11% -$6.68K 0.01% 154
2023
Q3
$65K Buy
1,993
+144
+8% +$5.09K 0.02% 133
2023
Q2
$66K Buy
1,849
+206
+13% +$8.02K 0.02% 141
2023
Q1
$84K Buy
1,643
+857
+109% +$37K 0.02% 112
2022
Q4
$34K Hold
786
0.01% 175
2022
Q3
$34K Sell
786
-10
-1% -$486 0.01% 177
2022
Q2
$42K Buy
796
+56
+8% +$2.85K 0.01% 153
2022
Q1
$38K Buy
740
+100
+16% +$5.19K 0.01% 146
2021
Q4
$38K Sell
640
-100
-14% -$4.96K 0.01% 143
2021
Q3
$32K Buy
740
+100
+16% +$4.43K 0.01% 156
2021
Q2
$25K Sell
640
-627
-49% -$24.4K 0.01% 163
2021
Q1
$46K Sell
1,267
-100
-7% -$3.55K 0.02% 123
2020
Q4
$50K Sell
1,367
-348
-20% -$12.8K 0.02% 123
2020
Q3
$60K Buy
1,715
+106
+7% +$3.72K 0.02% 84
2020
Q2
$50K Hold
1,609
0.02% 92
2020
Q1
$50K Buy
+1,609
New +$54.8K 0.02% 84

Other funds holding PFE

Avion Wealth's PFE Position: Q2 2026 in Review

Avion Wealth reduced its Pfizer (PFE) stake by 0.81% in Q2 2026, selling an estimated $366 and leaving 1,719 shares worth $41K. The position accounts for 0.01% of the portfolio, ranked #270.

Avion Wealth first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $84K in Q1 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Avion Wealth held 1,719 shares of Pfizer worth $41K as of Q2 2026.
  • Avion Wealth sold 14 Pfizer shares in Q2 2026, an estimated $366.
  • Pfizer made up 0.01% of Avion Wealth's portfolio in Q2 2026, its #270 holding.
  • Avion Wealth first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Avion Wealth's Pfizer position peaked at $84K in Q1 2023.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.